Phase III trial of PF-07220060 and fulvestrant in HR+/HER2- breast cancer

584K views

VJOncology

1 year ago

Phase III trial of PF-07220060 and fulvestrant in HR+/HER2- breast cancer

Phase III trial of PF-07220060 and fulvestrant in HR+/HER2- breast cancer